Eli Lilly has developed tirzepatide, a novel, first-in-class, 15 synthetic peptide designed to be a dual agonist of GLP-1 and GIP 22
Because this fragment doesnt engage the standard hGH receptor pathway, it also doesnt register on the WADA hGH isoform immunoassay a detail confirmed in peer-reviewed pharmacology research and one of the clearest proof points that AOD-9604s mechanism is genuinely distinct from full hGH, not just a smaller dose of the same effect
(2005) found that GHK-Cu cream improved skin laxity, reduced wrinkles, increased skin density and thickness, and strongly stimulated dermal keratinocyte proliferation
Whether its slow recovery, chronic inflammation, or unexplained fatigue, the goal is to trace it back to a measurable disruption something we can map, track, and correct with precision